SEC Form 4 · accession 0001437749-18-007217
Sun BioPharma, Inc. · SNBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan Horvath
Officer — V.P. of Finance & CFO
Period of report
Apr 17, 2018
Accepted (ET)
Apr 19, 2018 · 6:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001029125
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $5.75 | Apr 17, 2018 | A | 40,000 | A | — | Apr 17, 2028 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1Options scheduled to vest in four equal installments annually, starting April 17, 2018.